Immunological Reactivity of Blood from Healthy Humans to the rAls3p-N Vaccine Protein

被引:16
作者
Baquir, Beverlie [1 ]
Lin, Lin [1 ]
Ibrahim, Ashraf S. [1 ,3 ]
Fu, Yue [1 ,3 ]
Avanesian, Valentina [1 ]
Tu, Ang [1 ]
Edwards, John, Jr. [1 ,3 ]
Spellberg, Brad [1 ,2 ,3 ]
机构
[1] Harbor Univ Calif Los Angeles, Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA USA
[2] Harbor Univ Calif Los Angeles, Med Ctr, Div Gen Internal Med, Torrance, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
STREPTOCOCCUS-PNEUMONIAE; ANTIBODY; EPIDEMIOLOGY; INFECTIONS; PROTECTION; CHILDREN; INFANTS; AGE;
D O I
10.1086/649901
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We determined reactivity of human blood to a vaccine based on the recombinant N-terminus of candidal Als3p (rAls3p-N) in preparation for future clinical trials. Healthy donor plasma had high immunoglobulin Gtiters (median, 1:51,200) and lower immunoglobulin A (median, 1:3,200) and immunoglobulin E (median, 1:128) titers to rAls3p-N by enzyme-linked immunosorbent assay. rAls3p-N stimulated interferon gamma (IFN-gamma) and interleukin (IL)-17, but not IL-4, from donor lymphocytes by enzyme-linked immunosorbent spot assay and IL-12 p70, IFN-gamma, IL-17, and IL-10 by cytometric bead array. Donors reacted to diverse immunodominant epitopes. Thus, facile humoral and cellular assays can monitor immune responses to the rAls3p-N vaccine in planned clinical trials.
引用
收藏
页码:473 / 477
页数:5
相关论文
共 17 条
[1]   A RANDOMIZED, PROSPECTIVE FIELD TRIAL OF A CONJUGATE VACCINE IN THE PROTECTION OF INFANTS AND YOUNG-CHILDREN AGAINST INVASIVE HAEMOPHILUS-INFLUENZAE TYPE-B DISEASE [J].
ESKOLA, J ;
KAYHTY, H ;
TAKALA, AK ;
PELTOLA, H ;
RONNBERG, PR ;
KELA, E ;
PEKKANEN, E ;
MCVERRY, PH ;
MAKELA, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (20) :1381-1387
[2]   EPIDEMIOLOGICAL-STUDIES OF STREPTOCOCCUS-PNEUMONIAE IN INFANTS - ANTIBODY TO TYPE-3, TYPE-6, TYPE-14, AND TYPE-23 IN THE 1ST 2 YEARS OF LIFE [J].
GRAY, BM ;
DILLON, HC .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (05) :948-955
[3]   Candida albicans ALS3 and insights into the nature of the ALS gene family [J].
Hoyer, LL ;
Payne, TL ;
Bell, M ;
Myers, AM ;
Scherer, S .
CURRENT GENETICS, 1998, 33 (06) :451-459
[4]   Age-dependent preference in human antibody responses to Streptococcus pneumoniae polypeptide antigens [J].
Lifshitz, S ;
Dagan, R ;
Shani-Sekler, M ;
Grossman, N ;
Fleminger, G ;
Friger, M ;
Nebenzahl, YM .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (02) :344-353
[5]  
LIN L, PLOS PATHOG IN PRESS
[6]   Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant [J].
Lin, Lin ;
Ibrahim, Ashraf S. ;
Avanesian, Valentina ;
Edwards, John E., Jr. ;
Fu, Yue ;
Baquir, Beverlie ;
Taub, Rebecca ;
Spellberg, Brad .
CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (03) :582-584
[7]   Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus [J].
Lin, Lin ;
Ibrahim, Ashraf S. ;
Baquir, Beverlie ;
Avanesian, Valentina ;
Fu, Yue ;
Spellberg, Brad .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2009, 55 (03) :293-295
[8]   Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for Prevention [J].
Lynch, Joseph P., III ;
Zhanel, George G. .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 30 (02) :189-209
[9]   ANTIBODY TO CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS-PNEUMONIAE - PREVALENCE, PERSISTENCE, AND RESPONSE TO REVACCINATION [J].
MUSHER, DM ;
GROOVER, JE ;
ROWLAND, JM ;
WATSON, DA ;
STRUEWING, JB ;
BAUGHN, RE ;
MUFSON, MA .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (01) :66-73
[10]  
PELTOLA H, 1977, PEDIATRICS, V60, P730